DELIVERY ORDER
Active75N93026F00001
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH NIAID
$111.1K
obligated · signed 1 week ago
C02 - PK-PD ANALYSIS OF MOUSE MODEL EFFICACY AND PK DATA FOR ANTIBACTERIAL COMPOUNDS
Performance timeline
Start
Sep 25, 2026
End
Jul 14, 2031
with all options
Loading status
Estimated start: Jul 14, 2030
INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
Contract 75N93026F00001
UEI
Z82HHPY83MC7
Parent Company
INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 20
Current Obligation
$111,080
Base + Exercised Options
$111,080
Total Ceiling Value
$333,240
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Place of Performance
Congressional District: 20
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Contract Vehicle
75N93024D00013
IDCDepartment of Health and Human Services
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.